Category: Press Release

CAPSTONE THERAPEUTICS CORP. ANNOUNCES TRANSACTION WITH DIAMOND PRODUCTS HOLDINGS, LLC

CAPSTONE THERAPEUTICS ANNOUNCES OPERATING RESULTS FOR FISCAL 2020 – INCLUDING A CHANGE IN ITS DEFERRED TAX VALUATION ALLOWANCE

CAPSTONE THERAPEUTICS ANNOUNCES RESULTS OF SPECIAL SHAREHOLDER MEETING, AND A LICENSE TRANSFER/ROYALTY AGREEMENT AND EXIT FROM THE PHARMACEUTICAL DEVELOPMENT BUSINESS

Capstone Therapeutics Announces Exercise of Secured Debt and Interest Conversion Option by BP Peptides, LLC and Change in Control

Capstone Therapeutics Annouces Transaction With TotalStone LLC

LipimetiX Development Announces Sub-License of APO E Mimetic Peptide Platform to Anji Pharma, China

CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION FOR SALE OF SHARES OF ITS COMMON STOCK and SECURED LOAN